Gujarat Magazine

Peripheral T Cell Lymphomas Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Celleron Therapeutics, Myeloid Therapeutics, Astex Pharma

Peripheral T Cell Lymphomas Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Celleron Therapeutics, Myeloid Therapeutics, Astex Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Peripheral T Cell Lymphomas pipeline constitutes 40+ key companies continuously working towards developing 40+ Peripheral T Cell Lymphomas treatment therapies,

Read Full Article

Sleep Apnea Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights By DelveInsight | Axsome Therapeutics/Jazz Pharma, Bioprojet Pharma, Taisho Pharma, Takeda

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Sleep Apnea pipeline constitutes 10+ key companies continuously working towards developing 14+ Sleep Apnea treatment therapies, analysis of Clinical Trials,

Read Full Article

Spinal Muscular Atrophy Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc., Ionis Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of

Read Full Article

Fuchs Endothelial Corneal Dystrophy Pipeline Fuels Robust Market Growth Through 2034 | DelveInsight

Fuchs Endothelial Corneal Dystrophy Pipeline Insight – DelveInsight The Fuchs Endothelial Corneal Dystrophy (FECD) treatment landscape is poised for significant advancement, driven by innovative regenerative therapies and targeted approaches from

Read Full Article

Motion Sickness Treatment Market Poised for Significant Growth by 2032, Driven by Advances in Drug Delivery Systems and a Booming Travel Industry | DelveInsight

Nausea and Vomiting Induced by Motion Sickness DelveInsight The nausea and vomiting induced by motion sickness treatment market is anticipated to experience notable growth. The increasing prevalence of motion sickness

Read Full Article

Stargardt Disease Market Projected to Grow at a Significant CAGR Through 2034, Driven by a Promising Pipeline and Recent Developments | DelveInsight

Stargardt Disease Market Insight DelveInsight The Stargardt disease market is poised for remarkable growth over the next decade, driven by an expanding pipeline of innovative therapies, increasing disease awareness, improved

Read Full Article

Facial Lines Market Set for Significant Transformation by 2032, Forecasts DelveInsight

Facial Lines Market Facial Lines Companies working in the market are Ipsen, Evolus, Inc., and others. (Albany, USA) DelveInsight’s “Facial Lines – Market Insight, Epidemiology, And Market Forecast – 2032″

Read Full Article

Hemophilia B Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Pipeline, Revenue, Statistics, Epidemiology and Companies by DelveInsight

Hemophilia B Drugs Market Hemophilia B companies are UniQure Biopharma B.V., CSL Behring, Pfizer/Spark Therapeutics, Genzyme, a Sanofi Company, Alnylam Pharmaceuticals, Novo Nordisk, Pfizer, UniQure Biopharma B.V., ApcinteX Ltd, Freeline

Read Full Article

Hormone Replacement Therapy Market Set to Grow at 6.48% CAGR Through 2030, Driven by Rising Demand | DelveInsight

Hormone Replacement Therapy Market Hormone Replacement Therapy companies working in the market are Abbott, Novartis AG, Pfizer Inc., Merck KGaA,

Read Full Article

Voltage Stasis Tech LLC Unveils Groundbreaking MPTS System, Ushering in a New Era of Over 95% Power Efficiency for Commercial and Industrial Facilities

Voltage Stasis Tech LLC, in collaboration with TransPower Company, has launched its innovative Maximum Power Transfer Solution (MPTS), a state-of-the-art

Read Full Article

Atopic Dermatitis Market Size in 7MM was ~USD 17 billion in 2023, and is expected to increase by 2034, estimates DelveInsight

DelveInsight’s “Atopic Dermatitis Treatment Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of all Atopic

Read Full Article

Postpartum Depression Treatment Market Size in the 7MM was estimated to be USD 260 million in 2023, and is expected to increase a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Postpartum Depression Treatment Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of all Postpartum

Read Full Article

Asthma Therapeutics Market Size in 7MM was ~USD 20,633 million in 2023 and is anticipated to grow with a significant CAGR of 1.6% by 2034, estimates DelveInsight

DelveInsight’s “Asthma Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of asthma, historical and forecasted

Read Full Article

MASH Market Size in the 7MM was ~USD 1.8 billion in 2023, is projected to grow at a CAGR of 24%, estimates DelveInsight

DelveInsight’s “MASH Treatment Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of MASH, historical and

Read Full Article

Prostate Cancer Treatment Market Size in the 7MM was ~USD 12,300 million in 2023 and is expected to show positive growth by 2034, estimates DelveInsight

DelveInsight’s “Prostate Cancer Treatment Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of all prostate

Read Full Article

Acromegaly Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Statistics, Revenue, Medication, Therapies, Treatment Market and Companies by DelveInsight

Acromegaly Drugs Market Acromegaly companies are Amolyt Pharma, Amryt Pharma Plc, Antisense Therapeutics Ltd, Aquestive Therapeutics Inc, ASCIL Biopharm, Camurus

Read Full Article

Celiac Disease Market Analysis 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Statistics, Revenue, Prevalence, Medication, Treatment Market and Companies by DelveInsight

Celiac Disease Market Celiac Disease Companies working in the treatment market are Sanofi (Provention Bio), Zedira, Dr. Falk Pharma, Takeda,

Read Full Article

Traumatic Brain Injury Market Analysis 2034: EMA, PDMA, FDA Approval, Medication, Clinical Trials, Epidemiology, Therapies, Statistics, Revenue, Treatment Market and Companies by DelveInsight

Traumatic Brain Injury Market Traumatic Brain Injury companies include Abalonex, LLC, The SanBio Group, VeriNOS Pharmaceuticals GmbH, Hope Biosciences, Merz

Read Full Article

Spinal Muscular Atrophy Pipeline Drugs Analysis 2025: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Treatment Market, NDA Approval, Therapies, ROA, MOA and Companies by DelveInsight

Spinal Muscular Atrophy Pipeline Spinal Muscular Atrophy companies are Amniotics, Biohaven Pharmaceuticals, Hoffmann-La Roche, Amylon Therapeutics, Voyager Therapeutics, Catalyst Pharmaceuticals,

Read Full Article

Ulcerative Colitis Drugs Market 2034: Clinical trials, EMA, PDMA, FDA Approvals, Medication, Statistics, Revenue, Therapies, Prevalence and Companies by DelveInsight

Ulcerative Colitis Drugs Market Ulcerative Colitis companies are Celgene (Bristol-Myers Squibb), Reistone Biopharma, Galapagos NV, InDex Pharmaceuticals, Boehringer Ingelheim, Protagonist

Read Full Article

Recent Posts

Peripheral T Cell Lymphomas Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Celleron Therapeutics, Myeloid Therapeutics, Astex Pharma

Read Full Article

Categories